Secondary Logo

Institutional members access full text with Ovid®

Will precision medicine be available for all patients in the near future?

Gómez, René Maximilianoa; Ansotegui, Ignaciob; Canonica, Giorgio W.c

Current Opinion in Allergy and Clinical Immunology: February 2019 - Volume 19 - Issue 1 - p 75–80
doi: 10.1097/ACI.0000000000000491

Purpose of review Evidence-based medicine and guidelines directing the diagnosis and treatment of patients are changing. General recommendations are moving towards an individual focus, where technology evolution allows identification of specific patterns and where ‘one size fits all’ no longer has a place.

Recent findings Emerging innovations on health technology include useful tools for individualizing patients’ specific conditions and follow-up. There are several preventive initiatives that aim to reduce allergic disease development, but they have no generalizable and definitive results as yet. Both omics and molecular diagnosis have provided the basis for differentiating clusters of patients, both allowing prediction of severity and also indicating appropriate management. Here we discuss examples contributing to some specific conditions we are now facing.

Summary Precision medicine encompasses a personalized care of the patient, the prediction of a successful treatment, the potential prevention of a disease and its progression when present and the important active participation of the patient in the planning and guidance of the approach and management. Technology and medical innovations like omics and molecular diagnosis help for discriminating specific phenotypes/endotypes and the correct individualized interventions. The great challenge for implementing precision medicine will be the possibility of providing those advances to everyone at affordable costs.

Conclusion Technology and innovations in medicine are aimed to help all patients globally, providing evidence for particular conditions that need to be personally considered, involving the patient's decision while treating, predicting and preventing disease. Our aim should be to have precision medicine available everywhere at any time.

aSchool of Health Sciences, Catholic University of Salta, Argentina

bHospital Quirónsalud Bizkaia, Bilbao, Spain

cHumanitas University and Research Hospital, Milano, Italy

Correspondence to René Maximiliano Gómez, Sarmiento 771, Salta 4400, Argentina. Tel: +54 9 387 464 5561; fax: +54 387 432 0886; e-mails:,

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.